Literature DB >> 11864124

Epidemiology of Staphylococcus aureus bacteremia in Denmark from 1957 to 1990.

Niels Frimodt-Møller1, Frank Espersen, Peter Skinhøj, Vibeke Thamdrup Rosdahl.   

Abstract

OBJECTIVE: To investigate the changes in epidemiology of Staphylococcus aureus (SA) bacteremia in Denmark over a 30-year period, where the population has remained stable.
METHODS: Bacteriologic and clinical data were generated on 17 712 SA strains from virtually all SA bacteremia cases in Denmark from 1957 to 1990 submitted to our laboratory for phage typing. The data were related to information about population, hospital activity and blood-culturing activity during that period.
RESULTS: SA bacteremia cases increased from 3 to 20/100 000 inhabitants per year, with the largest increases in incidence rates for the <1-year and >50-year age groups. While blood-culturing activity increased three-fold during the period, the rate of SA bacteremias actually decreased relative to the number of blood cultures taken. The increase in SA bacteremia cases was mainly due to increases in nosocomial infections for all age groups and was related to the increasing admission rates to Danish hospitals. Major shifts in antibiotic resistance patterns and phage types took place during the period, i.e. a marked reduction in multiresistant (including methicillin-resistant) strains, but could not explain the change in the epidemiology of the infections.
CONCLUSIONS: The data indicate that increases in SA bacteremia rates correlated significantly with increasing numbers of admissions to hospitals. The main increase in SA bacteremia rates was represented by nosocomial infection, although increasing blood-culturing activity during the period may have contributed.

Entities:  

Year:  1997        PMID: 11864124     DOI: 10.1111/j.1469-0691.1997.tb00617.x

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  14 in total

1.  Molecular characterization of methicillin-resistant Staphylococcus epidermidis clones: evidence of geographic dissemination.

Authors:  Maria Miragaia; Isabel Couto; Sandro F F Pereira; Karl G Kristinsson; Henrik Westh; Jens O Jarløv; João Carriço; Jonas Almeida; Ilda Santos-Sanches; Hermínia de Lencastre
Journal:  J Clin Microbiol       Date:  2002-02       Impact factor: 5.948

2.  Time trends in Staphylococcus aureus bacteremia, 1988-2010, in a tertiary center with high methicillin resistance rates.

Authors:  Dafna Yahav; Hila Shaked; Elad Goldberg; Sharief Yassin; Noa Eliakim-Raz; Mical Paul; Jihad Bishara; Leonard Leibovici
Journal:  Infection       Date:  2016-07-13       Impact factor: 3.553

3.  Association of Evidence-Based Care Processes With Mortality in Staphylococcus aureus Bacteremia at Veterans Health Administration Hospitals, 2003-2014.

Authors:  Michihiko Goto; Marin L Schweizer; Mary S Vaughan-Sarrazin; Eli N Perencevich; Daniel J Livorsi; Daniel J Diekema; Kelly K Richardson; Brice F Beck; Bruce Alexander; Michael E Ohl
Journal:  JAMA Intern Med       Date:  2017-10-01       Impact factor: 21.873

Review 4.  Population-based epidemiology and microbiology of community-onset bloodstream infections.

Authors:  Kevin B Laupland; Deirdre L Church
Journal:  Clin Microbiol Rev       Date:  2014-10       Impact factor: 26.132

5.  Trends and outcome of nosocomial and community-acquired bloodstream infections due to Staphylococcus aureus in Finland, 1995-2001.

Authors:  O Lyytikäinen; E Ruotsalainen; A Järvinen; V Valtonen; P Ruutu
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-06       Impact factor: 3.267

Review 6.  Future challenges and treatment of Staphylococcus aureus bacteremia with emphasis on MRSA.

Authors:  Rasmus V Rasmussen; Vance G Fowler; Robert Skov; Niels E Bruun
Journal:  Future Microbiol       Date:  2011-01       Impact factor: 3.165

Review 7.  Development of a vaccine against Staphylococcus aureus.

Authors:  Brad Spellberg; Robert Daum
Journal:  Semin Immunopathol       Date:  2011-11-14       Impact factor: 9.623

8.  Staphylococcus aureus bloodstream infections in children: A population-based assessment.

Authors:  Otto G Vanderkooi; Daniel B Gregson; James D Kellner; Kevin B Laupland
Journal:  Paediatr Child Health       Date:  2011-05       Impact factor: 2.253

9.  NDV-3, a recombinant alum-adjuvanted vaccine for Candida and Staphylococcus aureus, is safe and immunogenic in healthy adults.

Authors:  Clint S Schmidt; C Jo White; Ashraf S Ibrahim; Scott G Filler; Yue Fu; Michael R Yeaman; John E Edwards; John P Hennessey
Journal:  Vaccine       Date:  2012-10-22       Impact factor: 3.641

10.  Prevalence and outcomes of antimicrobial treatment for Staphylococcus aureus bacteremia in outpatients with ESRD.

Authors:  Kevin E Chan; H Shaw Warren; Ravi I Thadhani; David J R Steele; Jeffrey L Hymes; Franklin W Maddux; Raymond M Hakim
Journal:  J Am Soc Nephrol       Date:  2012-08-16       Impact factor: 10.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.